In this discussion, Professors Christoph Correll and Gabriele Fischer address the complexities of treating patients with co-occurring schizophrenia and substance use disorders. The conversation covers the challenges of managing the comorbidity of these disorders.
Related content
Continuous maintenance therapy is associated with a lower risk of relapse than intermittent treatment, supporting ongoing treatment strategies in schizophrenia and related psychotic disorders.
Treatment response tends to be higher during a first episode than during subsequent episodes, emphasizing the importance of early intervention and effective management.
Negative symptoms are a core feature of schizophrenia and can have a profound impact on functioning, social relationships, and quality of life.